2-218992167-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong

The NM_057093.2(CRYBA2):​c.238G>A​(p.Ala80Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000206 in 1,613,338 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 0 hom. )

Consequence

CRYBA2
NM_057093.2 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 3.10
Variant links:
Genes affected
CRYBA2 (HGNC:2395): (crystallin beta A2) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of the vertebrate eye, which function to maintain the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also defined as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group but absent in the acidic group). Beta-crystallins form aggregates of different sizes and are able to form homodimers through self-association or heterodimers with other beta-crystallins. This gene is a beta acidic group member. Three alternatively spliced transcript variants encoding identical proteins have been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM1
In a chain Beta-crystallin A2 (size 196) in uniprot entity CRBA2_HUMAN there are 4 pathogenic changes around while only 1 benign (80%) in NM_057093.2
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.042640954).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CRYBA2NM_057093.2 linkuse as main transcriptc.238G>A p.Ala80Thr missense_variant 2/4 ENST00000295728.7 NP_476434.1
CRYBA2NM_057094.2 linkuse as main transcriptc.238G>A p.Ala80Thr missense_variant 3/5 NP_476435.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CRYBA2ENST00000295728.7 linkuse as main transcriptc.238G>A p.Ala80Thr missense_variant 2/41 NM_057093.2 ENSP00000295728 P1
CRYBA2ENST00000392096.6 linkuse as main transcriptc.238G>A p.Ala80Thr missense_variant 3/51 ENSP00000375946 P1
CRYBA2ENST00000453769.1 linkuse as main transcriptc.238G>A p.Ala80Thr missense_variant 3/43 ENSP00000395120
CRYBA2ENST00000490678.1 linkuse as main transcriptn.240G>A non_coding_transcript_exon_variant 2/22

Frequencies

GnomAD3 genomes
AF:
0.000223
AC:
34
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000169
AC:
42
AN:
248948
Hom.:
0
AF XY:
0.000200
AC XY:
27
AN XY:
134942
show subpopulations
Gnomad AFR exome
AF:
0.0000619
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000299
Gnomad EAS exome
AF:
0.000490
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000260
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000204
AC:
298
AN:
1461150
Hom.:
0
Cov.:
31
AF XY:
0.000187
AC XY:
136
AN XY:
726874
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.000230
Gnomad4 EAS exome
AF:
0.000277
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000242
Gnomad4 OTH exome
AF:
0.000149
GnomAD4 genome
AF:
0.000223
AC:
34
AN:
152188
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.0000724
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000279
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000278
Hom.:
0
Bravo
AF:
0.000208
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000148
AC:
18
EpiCase
AF:
0.000164
EpiControl
AF:
0.000356

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 07, 2023The c.238G>A (p.A80T) alteration is located in exon 2 (coding exon 2) of the CRYBA2 gene. This alteration results from a G to A substitution at nucleotide position 238, causing the alanine (A) at amino acid position 80 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
CRYBA2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesOct 31, 2022The CRYBA2 c.238G>A variant is predicted to result in the amino acid substitution p.Ala80Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.055% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-219856889-C-T), which may be too frequent for a pathogenic variant in CRYBA2. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T;T;T
Eigen
Benign
-0.010
Eigen_PC
Benign
0.055
FATHMM_MKL
Benign
0.52
D
LIST_S2
Uncertain
0.92
.;D;D
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.043
T;T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
-0.71
N;N;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.54
N;N;N
REVEL
Uncertain
0.31
Sift
Benign
0.45
T;T;T
Sift4G
Benign
0.63
T;T;.
Polyphen
0.80
P;P;.
Vest4
0.43
MVP
0.83
MPC
0.72
ClinPred
0.084
T
GERP RS
3.6
Varity_R
0.16
gMVP
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200129430; hg19: chr2-219856889; API